Group 1 - The core point of the news is that Anglikang's stock price increased by 5.09%, reaching 44.81 CNY per share, with a trading volume of 1.039 billion CNY and a turnover rate of 12.94%, resulting in a total market capitalization of 9.039 billion CNY [1] - Anglikang Pharmaceutical Co., Ltd. is located in Shengzhou, Zhejiang Province, and was established on December 30, 2001. The company was listed on October 23, 2018, and its main business involves the research, production, and sales of chemical raw materials and formulations [1] - The revenue composition of Anglikang's main business includes formulations at 43.46%, raw materials at 39.82%, specialty intermediates at 12.44%, other products at 3.72%, and pharmaceutical excipients at 0.56% [1] Group 2 - From the perspective of major fund holdings, one fund under Tongtai Fund has a significant position in Anglikang. The Tongtai Health Theme Mixed A Fund (011002) held 66,200 shares in the third quarter, accounting for 4.99% of the fund's net value, making it the sixth-largest holding [2] - The Tongtai Health Theme Mixed A Fund (011002) was established on April 8, 2021, with a latest scale of 13.7512 million CNY. Year-to-date, it has achieved a return of 21.89%, ranking 4112 out of 8147 in its category; over the past year, it has returned 9.34%, ranking 5366 out of 8056; since inception, it has incurred a loss of 49.99% [2] Group 3 - The fund managers of Tongtai Health Theme Mixed A Fund (011002) are Ma Yi and Mai Jianpei. As of the report, Ma Yi has a cumulative tenure of 11 years and 241 days, with a total fund asset size of 2.718 billion CNY, achieving a best fund return of 45.64% and a worst return of -0.63% during his tenure [3] - Mai Jianpei has a cumulative tenure of 185 days, with a total fund asset size of 231 million CNY, achieving a best fund return of 21.48% and a worst return of -1.56% during his tenure [3]

Core Viewpoint - 甘化科工's stock has experienced fluctuations, with a year-to-date increase of 42.42% but a recent decline in the last five, twenty, and sixty trading days [1][2] Financial Performance - For the period from January to September 2025, 甘化科工 reported revenue of 361 million yuan, representing a year-on-year growth of 29.73%, and a net profit attributable to shareholders of 77.53 million yuan, which is an increase of 287.11% compared to the previous year [2] Stock Market Activity - As of November 12, 甘化科工's stock price was 10.34 yuan per share, with a market capitalization of 4.513 billion yuan. The stock saw a trading volume of 46.91 million yuan and a turnover rate of 1.04% [1] - The company has appeared on the龙虎榜 twice this year, with the most recent appearance on May 16, where it recorded a net buy of 172,900 yuan [1] Shareholder Information - As of September 30, 2025, 甘化科工 had 37,900 shareholders, a decrease of 1.63% from the previous period, with an average of 11,443 circulating shares per shareholder, which is an increase of 1.65% [2] - The top three circulating shareholders include 中欧高端装备股票发起A, which increased its holdings by 6.11 million shares, and 长信国防军工量化混合A, which is a new entrant among the top shareholders [3] Business Overview - 甘化科工, established in April 1993 and listed in September 1994, operates in the LED industry, biochemical industry, paper trading, and military industry. The revenue composition is 52.01% from high-performance special alloy materials and 47.03% from power supply and related products [1][2] Dividend Information - Since its A-share listing, 甘化科工 has distributed a total of 216 million yuan in dividends, with no dividends paid in the last three years [3]

Core Viewpoint - Dongshan Precision experienced a decline of 5.01% on November 12, with a stock price of 72.10 CNY per share and a total market capitalization of 132.06 billion CNY [1] Company Overview - Dongshan Precision Manufacturing Co., Ltd. is located in Suzhou, Jiangsu Province, and was established on October 28, 1998. The company went public on April 9, 2010. Its main business includes the manufacturing and service of precision sheet metal parts and precision castings, as well as flexible circuit board design, production, and sales [1] - The revenue composition of the company is as follows: electronic circuit products 65.23%, touch panels and LCD display modules 17.98%, precision components 13.93%, LED display devices 1.69%, and others 1.17% [1] Shareholder Information - The top circulating shareholder of Dongshan Precision includes a fund from Ruifeng Fund, specifically Ruifeng Growth Value Mixed A (007119), which entered the top ten circulating shareholders in the third quarter with 21.34 million shares, accounting for 1.54% of circulating shares. The estimated floating loss today is approximately 81.1 million CNY [2] - Ruifeng Growth Value Mixed A (007119) was established on March 26, 2019, with a latest scale of 21.39 billion CNY. Year-to-date returns are 58.33%, ranking 531 out of 8147 in its category; the one-year return is 50.3%, ranking 494 out of 8056; and since inception, the return is 89.24% [2] Fund Manager Information - The fund managers of Ruifeng Growth Value Mixed A (007119) are Fu Pengbo and Zhu Lin. Fu has a cumulative tenure of 16 years and 304 days, with the fund's total asset scale at 23.63 billion CNY, achieving a best return of 429.69% and a worst return of -3.8% during his tenure [3] - Zhu has a cumulative tenure of 6 years and 234 days, with the same fund asset scale of 23.63 billion CNY, achieving a best return of 91.85% and a worst return of 86.83% during his tenure [3] Fund Holdings - Ruifeng Growth Value Mixed A (007119) has Dongshan Precision as one of its top holdings, with 21.34 million shares, representing 6.46% of the fund's net value, making it the seventh-largest holding. The estimated floating loss today is approximately 81.1 million CNY [4]

Core Insights - The stock price of Kory Technology has decreased by 2.01% to 20.51 CNY per share as of November 12, with a market capitalization of 8.614 billion CNY [1] - The company has seen a year-to-date stock price increase of 32.14%, but has experienced a decline of 3.75% over the last five trading days [1] Financial Performance - For the period from January to September 2025, Kory Technology reported a revenue of 1.761 billion CNY, representing a year-on-year growth of 0.22%, while the net profit attributable to shareholders was 247 million CNY, showing a significant increase of 49.79% [2] - The company has distributed a total of 431 million CNY in dividends since its A-share listing, with 240 million CNY distributed over the past three years [2] Shareholder Information - As of October 31, 2025, the number of shareholders for Kory Technology increased by 13.07% to 39,600, while the average number of circulating shares per shareholder decreased by 11.56% to 10,581 shares [2] - The top ten circulating shareholders include various ETFs and investment funds, with notable changes in holdings among major shareholders [3]

Group 1 - The stock price of Sanhuan Group has dropped by 5.03% to 46.84 CNY per share, with a total market capitalization of 89.769 billion CNY, and a cumulative decline of 7.99% over the last three days [1] - Sanhuan Group, established on December 10, 1992, specializes in the research, production, and sales of electronic components and their basic materials, with 98.84% of its revenue coming from electronic and communication components [1] Group 2 - The fund "Zhongtai Xingrui Prosperity Growth Mixed A" holds 40,700 shares of Sanhuan Group, representing 3% of the fund's net value, and has incurred a floating loss of approximately 100,900 CNY today [2] - The fund has achieved a year-to-date return of 29.75%, ranking 2918 out of 8147 in its category, and a one-year return of 19.32%, ranking 3475 out of 8056 [2] - The fund manager, Gao Lanjun, has a tenure of 6 years and 147 days, with the best fund return during this period being 126.62% [2]

Core Viewpoint - Sanxin Medical has shown a positive stock performance with a 5.07% increase, reaching a price of 10.36 CNY per share, and a total market capitalization of 5.409 billion CNY [1] Company Overview - Sanxin Medical Technology Co., Ltd. is located in Nanchang, Jiangxi Province, and was established on March 7, 1997, with its listing date on May 15, 2015 [1] - The company's main business involves the research, manufacturing, sales, and service of medical devices [1] - Revenue composition is as follows: blood purification products account for 82.23%, drug delivery devices for 10.83%, cardiothoracic surgery products for 4.60%, and other categories for 2.34% [1] Fund Holdings - Huian Fund has a significant holding in Sanxin Medical, with its Huian Asset Rotation Mixed A Fund (005360) being the largest shareholder [2] - In the third quarter, the fund reduced its holdings by 36,300 shares, maintaining a total of 117,100 shares, which represents 9.2% of the fund's net value [2] - The fund has achieved a year-to-date return of 10.07%, ranking 5958 out of 8147 in its category [2]

Group 1 - The core business of Xiaocheng Technology involves the integrated circuit design, research, production, and sales of power line carrier chips, providing complete solutions for power companies and energy meter suppliers, with main business revenue composition being 98.24% from gold and 1.76% from other sources [2] - As of October 31, 2025, the number of shareholders of Xiaocheng Technology increased by 2.40% to 64,800, with an average of 3,607 circulating shares per person, a decrease of 2.35% [2] - For the period from January to September 2025, Xiaocheng Technology achieved operating revenue of 379 million yuan, a year-on-year increase of 59.66%, and a net profit attributable to the parent company of 76.8 million yuan, up 88.94% year-on-year [2] Group 2 - Xiaocheng Technology's stock price has increased by 68.33% year-to-date, with a recent 2.12% increase over the last five trading days, a 15.46% decrease over the last 20 days, and a 28.92% increase over the last 60 days [1] - The company has appeared on the daily trading leaderboard 15 times this year, with the most recent appearance on October 9, where it recorded a net purchase of 58.62 million yuan, with total purchases amounting to 405 million yuan, accounting for 15.61% of total trading volume [1] - As of September 30, 2025, the second-largest circulating shareholder is the Gold ETF (517520) with 4.4993 million shares, an increase of 2.0268 million shares from the previous period, while new shareholders include Qianhai Kaiyuan Gold and Silver Jewelry Mixed A (001302) and Huaxia CSI Hong Kong and Shanghai Gold Industry Stock ETF (159562) [3]

Core Viewpoint - TianShun Wind Power's stock has experienced fluctuations, with a current price of 7.46 CNY per share, reflecting a year-to-date decline of 5.45% and a recent 20-day drop of 12.75% [1][2] Financial Performance - For the period from January to September 2025, TianShun Wind Power reported a revenue of 3.723 billion CNY, representing a year-on-year growth of 4.56%. However, the net profit attributable to shareholders decreased by 76.10% to 69.71 million CNY [2] - Cumulative cash dividends since the A-share listing amount to 1.426 billion CNY, with 171 million CNY distributed over the past three years [3] Shareholder Structure - As of November 10, 2025, the number of shareholders increased to 80,900, with an average of 22,074 circulating shares per shareholder, a decrease of 1.83% [2] - The top ten circulating shareholders include new entrants such as GF Multi-Factor Mixed Fund and HSBC Jintrust Small Cap Fund, indicating changes in institutional holdings [3] Market Activity - The stock's trading volume reached approximately 93.86 million CNY, with a turnover rate of 0.70% [1] - The main capital flow showed a net outflow of 894,300 CNY, with significant selling pressure compared to buying [1] Business Overview - TianShun Wind Power, established in 2005 and listed in 2010, specializes in the production and sales of wind towers and components, wind turbine blades, and related products, with a revenue composition of 53.62% from onshore wind equipment and 31.66% from power generation [1] - The company operates within the electric equipment sector, specifically focusing on wind power equipment and components [1]

Core Viewpoint - The stock of Diwei Er experienced a decline of 2.07% on November 12, trading at 42.60 yuan per share, with a market capitalization of 8.293 billion yuan. The company has seen a significant increase in stock price year-to-date, with a rise of 122.57% [1]. Group 1: Stock Performance - As of November 12, Diwei Er's stock price is 42.60 yuan per share, with a trading volume of 23.1575 million yuan and a turnover rate of 0.28% [1]. - The stock has increased by 122.57% year-to-date, with a slight decline of 0.70% over the last five trading days, a rise of 13.48% over the last 20 days, and an increase of 38.90% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Diwei Er achieved an operating income of 873 million yuan, representing a year-on-year growth of 9.86%. The net profit attributable to shareholders was 89.715 million yuan, reflecting a year-on-year increase of 40.59% [1]. - Since its A-share listing, Diwei Er has distributed a total of 134 million yuan in dividends, with 103 million yuan distributed over the past three years [2]. Group 3: Shareholder Information - As of September 30, 2025, Diwei Er had 4,884 shareholders, an increase of 8.53% from the previous period. The average number of circulating shares per shareholder was 39,858, a decrease of 7.86% [1]. - Among the top ten circulating shareholders, the Noan Pioneer Mixed A fund holds 8.7888 million shares, remaining unchanged from the previous period, while the Fortune Tianhui Growth Mixed A/B fund increased its holdings by 253,000 shares to 3.8007 million shares [2].

Core Viewpoint - Jinmoly Co., Ltd. has shown a significant stock price increase of 53.93% year-to-date, indicating strong market performance and investor interest [2] Group 1: Stock Performance - As of November 12, Jinmoly's stock price rose by 2.20% to 14.87 CNY per share, with a trading volume of 90.88 million CNY and a market capitalization of 47.98 billion CNY [1] - The stock has experienced a 3.19% increase over the last five trading days, a 2.62% decrease over the last 20 days, and a 13.86% increase over the last 60 days [2] Group 2: Company Overview - Jinmoly Co., Ltd. was established on May 16, 2007, and listed on April 17, 2008, primarily engaged in molybdenum mining, production, and sales of related products [2] - The company's revenue composition includes 90.14% from molybdenum mining and processing, 8.73% from commodity trading, and 1.14% from other sources [2] - Jinmoly is classified under the non-ferrous metals sector, specifically in the small metals category focusing on molybdenum [2] Group 3: Financial Performance - For the period from January to September 2025, Jinmoly reported a revenue of 10.885 billion CNY, reflecting a year-on-year growth of 7.80%, and a net profit attributable to shareholders of 2.286 billion CNY, up 4.17% year-on-year [2] - The company has distributed a total of 10.336 billion CNY in dividends since its A-share listing, with 3.549 billion CNY distributed over the past three years [3] Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders increased by 10.65% to 82,400, with an average of 39,134 circulating shares per shareholder, a decrease of 9.63% [2] - The top circulating shareholder is Hong Kong Central Clearing Limited, holding 76.305 million shares, a decrease of 12.6515 million shares from the previous period [3]